Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Muller

Showing results (701-710 of 784) with videos related to

Pageof 79
Sort By:
Contraception, Fertilite, Sexualite (1992)|February 17, 2000
[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients]J Saurel, M Rabreau, M Landi, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 2, 2006
Liver transplantation at Red Cross War Memorial Children's HospitalC W N Spearman, M McCulloch, A J W Millar, et al.
European Heart Journal|June 12, 2004
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, GreeceJohannes A Schaar, James E Muller, Erling Falk, et al.
The New England Journal of Medicine|January 30, 1986
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS StudyJ E Muller, Z G Turi, P H Stone, et al.
JACC. Cardiovascular Interventions|May 25, 2015
Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)Gregg W Stone, Akiko Maehara, James E Muller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2016
Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment-Elevation Myocardial InfarctionRyan D Madder, Rishi Puri, James E Muller, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2025
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driverSanne van den Berg, Marie G L Attwood, Pippa Griffin, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
Developmental Cell|October 29, 2020
Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary TumorsNevena B Ognjenovic, Meisam Bagheri, Gadisti Aisha Mohamed, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusionWouter van den Bijllaardt, Maarten J Schijffelen, Ron W Bosboom, et al.
Pageof 79

Showing results (701-710 of 784) with videos related to

Sort By:
Pageof 79
Contraception, Fertilite, Sexualite (1992)|February 17, 2000
[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients]J Saurel, M Rabreau, M Landi, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 2, 2006
Liver transplantation at Red Cross War Memorial Children's HospitalC W N Spearman, M McCulloch, A J W Millar, et al.
European Heart Journal|June 12, 2004
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, GreeceJohannes A Schaar, James E Muller, Erling Falk, et al.
The New England Journal of Medicine|January 30, 1986
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS StudyJ E Muller, Z G Turi, P H Stone, et al.
JACC. Cardiovascular Interventions|May 25, 2015
Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)Gregg W Stone, Akiko Maehara, James E Muller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2016
Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment-Elevation Myocardial InfarctionRyan D Madder, Rishi Puri, James E Muller, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2025
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driverSanne van den Berg, Marie G L Attwood, Pippa Griffin, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
Developmental Cell|October 29, 2020
Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary TumorsNevena B Ognjenovic, Meisam Bagheri, Gadisti Aisha Mohamed, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusionWouter van den Bijllaardt, Maarten J Schijffelen, Ron W Bosboom, et al.
Pageof 79